CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

NCT02047175 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Hyperlipidemia

Interventions

DRUG: Telmisartan/S-Amlodipine
DRUG: Rosuvastatin
DRUG: Telmisartan/S-Amlodipine + Rosuvastatin
DRUG: Telmisartan/S-Amlodipine + Rosuvastatin

Sponsor

Chong Kun Dang Pharmaceutical